Soaring demand from pharma clients triggers growth at healthcare consultants
Brighouse-based VISFO has seen demand for its healthcare consulting services and software platforms soar over the past year as global pharmaceutical clients look for more agile solutions.
The company has announced significant growth driven by demand for digital insights and software solutions as pharma and life sciences organisations accelerate their transformation strategies.
Its consultancy services grew by 200% during the same period from 2020 to 2021, with sales of its software platforms up 400%.
Pre lockdown, the business secured two new major global contracts, tripling its client base with a roster now spanning consumer health, biotech and pharma.
To support its success, VISFO has recruited 25 new staff despite the pandemic.
Most of the new recruits are software engineers, driving forward the development of the company’s software platforms, but key appointments have also been made expanding the medical writing team and digital insights and innovation function.
Dr Max Noble, CEO and founder of the business, said: “With our roots firmly grounded in science and medicine, we’re well placed to serve the growing needs of the pharma industry, utilising our problem-solving approach to allow clients to think differently and tackle healthcare challenges fuelled by cutting-edge data science, technology and validated insights.”
He said the greatest area of opportunity and development for the firm is within the digital insights and innovation offering, which has grown “exponentially” during the past year.
He added: “There’s no doubt that lockdown presented us all with some very serious challenges, but as a digital business we adapted quickly and successfully to virtual working.
“Appointing staff virtually is by no means easy but as most of our new recruits are already ‘cloud natives’, we have been able to expand based on the best minds and talent on the market.
“Our team is spread across the UK and into Europe now, with some based locally, others in London and even Spain. Location is no longer a constraint by which to be bound.”
VISFO says it now aims to become one of the largest healthtech businesses north of London in the next 12 months and the biggest in the UK in the next two years.
An overseas presence will follow as part of its three-year vision, with the company intending to establish offices in the US at the end of 2022.
